Michelle Yanez

Insider Reports History

Location
Tampa, FL
Signature
/s/ Michelle Yanez
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michelle Yanez:

Company Role Class Num Shares Value Price $ Report Date Ownership
Telomir Pharmaceuticals, Inc. Chief Financial Officer Common Stock 24,391 $151,224 $6.20 18 Jun 2024 Direct
Inhibitor Therapeutics, Inc. Director Common Stock 896,271 01 Apr 2025 Direct
Telomir Pharmaceuticals, Inc. Chief Financial Officer Incentive Stock Options (right to buy) 200,000 27 Aug 2024 Direct
MIRA PHARMACEUTICALS, INC. Chief Financial Officer Stock Options (right to buy) 150,000 09 Dec 2024 Direct
MIRA PHARMACEUTICALS, INC. Chief Financial Officer Incentive Stock Option (right to buy) 57,799 26 Mar 2024 Direct

Insider Reports Filed by Michelle Yanez

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INTI Inhibitor Therapeutics, Inc. 31 Dec 2024 1 $0 5 Director 19 Feb 2025, 21:27
MIRA MIRA PHARMACEUTICALS, INC. 09 Dec 2024 1 $0 4 Chief Financial Officer 10 Dec 2024, 17:15
TELO Telomir Pharmaceuticals, Inc. 27 Aug 2024 1 $0 4 Chief Financial Officer 04 Sep 2024, 13:37
TELO Telomir Pharmaceuticals, Inc. 18 Jun 2024 0 $0 3 Chief Financial Officer 29 Aug 2024, 16:05
INTI Inhibitor Therapeutics, Inc. 01 Apr 2024 1 $0 4 Director 07 Apr 2025, 17:25
INTI Inhibitor Therapeutics, Inc. 01 Apr 2024 1 $0 4 Director 16 May 2024, 13:34
MIRA MIRA PHARMACEUTICALS, INC. 26 Mar 2024 1 $0 4 Chief Financial Officer 27 Mar 2024, 17:53
MIRA MIRA PHARMACEUTICALS, INC. 17 Aug 2023 1 $0 4 CFO, Secretary and Treasurer 21 Aug 2023, 19:00
MIRA MIRA PHARMACEUTICALS, INC. 02 Aug 2023 0 $0 3 CFO, Secretary & Treasurer 02 Aug 2023, 18:10
INTI Inhibitor Therapeutics, Inc. 05 May 2023 1 $0 4 Director 17 May 2023, 19:09
INTI Inhibitor Therapeutics, Inc. 13 Dec 2022 0 $0 3 Director 22 Dec 2022, 20:33